BPC157 and TB500 are banned by WADA (the World Anti-Doping Agency) and by the NFL, UFC, NCAA, and other organizations
It also addresses fine lines, wrinkles, photodamage, and uneven pigmentation
Products are supplied with lot-level records and available assay documentation where applicable, so qualified researchers can reference identity, purity, and chain-of-custody information
Investigated in connection with normalizing sleep in intense training regimes
Research-grade products carry real risks of contamination, mislabeling, and inconsistent dosing
This could give it broader therapeutic potential for: As of 2025, Dihexa has not yet entered large-scale, double-blind, placebo-controlled clinical trials for widespread human use